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Abstract Autophagosome formation is a central event in mac-
roautophagy. The Apg12^Apg5 conjugate, which is essential in
this process, is generated by a ubiquitin-like protein conjugation
system. In yeast, Apg12, following activation by the E1-like
Apg7, forms a thioester with Apg10 (E2-like). Apg12 is ¢nally
conjugated to Apg5 via an isopeptide bond. The possible require-
ment of an E3-like protein for the conjugation, however, has not
yet been con¢rmed. The Apg12 system is conserved among eu-
karyotes, although a mammalian counterpart of Apg10 has not
yet been identi¢ed. Here, we report the identi¢cation and char-
acterization of the mouse Apg10 ortholog. A yeast two-hybrid
screen using the mouse Apg5 (mApg5) as bait identi¢ed a novel
protein with 19% identity to yeast Apg10. We designated this
protein mouse Apg10 (mApg10). We demonstrated by a modi-
¢ed yeast two-hybrid assay that mApg10 mediates the conjuga-
tion of mApg12 and mApg5. The in vivo interaction of mApg12
with mApg10 in HeLa cells suggests that mApg10 is an Apg12-
conjugating enzyme, likely serving as an Apg5-recognition mol-
ecule in the Apg12 system. This novel two-hybrid method, which
we have named ‘conjugation-mediated yeast two-hybrid’, proves
to be a simple and useful technique with which to analyze pro-
tein^protein conjugation.
2 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
A number of ubiquitin-like proteins (Ubls) have been dis-
covered [1,2], some of which are conjugated to substrates in a
manner similar to that seen in the ubiquitin system. At least
¢ve conjugation systems have been examined in detail : the
ubiquitin, SUMO (yeast Smt3), Nedd8 (yeast Rub1), Apg12
and Aut7/Apg8 systems. The conjugation reactions are cata-
lyzed by the concerted action of activating (E1) and conjugat-
ing (E2) enzymes, with the occasional involvement of E3 li-
gases. As ubiquitin is conjugated to hundreds of substrate
proteins [3], substrate speci¢city for ubiquitin conjugation is
mediated by E3 ubiquitin ligases (complexes). Most substrate
proteins of the SUMO system exhibit a consensus sequence,
8KxE, in which 8 is a large hydrophobic residue. This se-
quence is thought to be recognized by a single E2 (Ubc9) [4,5].
Recently, additional proteins of the Siz1 and PIAS families
were found to be required for SUMO conjugation in yeast
and mammalian cells, respectively [6^8]. These E3-equivalents
facilitate the conjugation reaction, rather than mediating sub-
strate recognition. In contrast to these systems, the Ubls
Nedd8, Apg12 and Aut7 each is conjugated to a single target
(family), the cullins [9^11], Apg5 [12] and phosphatidyletha-
nolamine (PE) [13], respectively.
The Apg12 and Aut7 systems are both required for the
formation of autophagosomes [12^17]. In mammalian cells,
Apg12^Apg5 conjugates localize to autophagic isolation mem-
branes [17]. The conjugation of Apg12 to Apg5, while not
required for membrane targeting of Apg5, is essential for
elongation of the membrane enclosing the portion of cyto-
plasm to be degraded. Aut7 and its mammalian homolog
LC3 localize to the autophagic isolation membrane in an
Apg12^Apg5-dependent manner [17,18]. In addition, PE-con-
jugation of yeast Aut7 is required for its localization to pre-
autophagosomal structures [18].
In yeast, both Apg12 and Aut7 are activated by a common
E1 enzyme, Apg7 [12,13,19^22]. Then, Apg12 and Aut7 form
thioesters with Apg10 [23] and Aut1/Apg3 [13], respectively.
Finally, Apg12 is conjugated to a lysine residue of Apg5,
whereas Aut7 is conjugated to PE. It is not known, however,
if this ¢nal step is mediated by the action of additional en-
zymes or by direct recognition of the substrate by Apg10 and
Aut1. As each Apg12 or Aut7 system has a single conjugation
substrate in contrast to the ubiquitin system, it is reasonable
that substrate recognition could be achieved by Apg10 or
Aut1 alone. The Apg12 and Aut7 systems appear to be con-
served in higher eukaryotes [16,17,24^27], although the mam-
malian counterpart of Apg10 has remained elusive.
In this study, we identi¢ed the mouse ortholog of Apg10
(mApg10) by yeast two-hybrid analysis using mouse Apg5 as
bait, suggesting the direct recognition of Apg5 by Apg10. We
also examined the function of mApg10 using a modi¢ed two-
hybrid method we have dubbed ‘conjugation-mediated yeast
two-hybrid analysis’.
2. Materials and methods
2.1. Plasmid construction
The cDNA encoding mouse Apg5 (mApg5) has been previously
described [17]. Mouse Apg7 (mApg7) cDNA was obtained from a
murine expressed sequence tag (EST) clone (uk25b08.y1). Mouse
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Apg12 (mApg12) cDNA was polymerase chain reaction (PCR)-ampli-
¢ed from total cDNA of a mouse cell line, BNL-CL2, using the prim-
ers 5P-CACTCCCGGGATGTCGGAAGATTCAGAGGT-3P and
5P-CATTCCCGGGTCATCCCCATGCCTGGGATT-3P. mApg10
cDNA was derived from the positive prey plasmid obtained by yeast
two-hybrid screen. To generate a bait plasmid, mApg5 cDNA was
cloned in-frame with the LexA coding sequence in plasmid
pBTM116 (provided by Drs. P. Bartel and S. Fields) to produce
pLex-mApg5. To determine the interactions between Apg proteins,
we subcloned the cDNAs of mApg12, mApg7, mApg10 and mApg5
into the pGBD-C1 and pGAD-C1 vectors [28]. To express mouse Apg
proteins in yeast cells, the cDNAs of mApg7 and mApg10 were re-
spectively cloned into the yeast constitutive expression vectors, pKT10
[29] and pKT10ADE, in which the URA3 gene is replaced by the
ADE2 gene. mApg12 and mApg5 cDNA were cloned into pG-1 to
generate pG1-m12 and pG1-m5, respectively. The fragment encoding
the GPD promoter-mApg12-PGK terminator was then excised from
pG1-m12 and cloned into the SmaI site of pG1-m5. This subsequent
cloning step generated pG1-m12m5, which encodes both mApg12 and
mApg5. Replacements of Cys567 of mApg7 with Ser and Cys165 of
mApg10 with Ser were performed using the Quick Change Site-di-
rected Mutagenesis Kit (Stratagene).
To analyze hApg12^mApg10 thioester formation, a cDNA encod-
ing the mApg10C165S mutant was cloned into the SmaI site of the
mammalian expression vector pCI-neo (Promega). Construction of
pHA-hApg12 was described previously [24].
2.2. Cell culture and transfection
The L40 Saccharomyces cerevisiae strain (MATa his3-v200 trp1-
v901 leu2-3, 112 ade2 LYS2 : :(lexAop)4-HIS3 URA3 : :(lexAop)8-
lacZ) was kindly provided by Drs. R. Sternglanz and S. Hollenberg.
The S. cerevisiae strain PJ69-4A (MATa trp1-901 leu2-3,112 ura3-52
his3-200 gal4v gal80v LYS2: :GAL1-HIS3 GAL2-ADE2 met2: :
GAL7-lacZ) was described previously [28]. Cells were grown either
in YPD medium (1% yeast extract, 2% peptone, 2% glucose) or in
SD medium containing nutritional supplements.
HeLa cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(Sigma) supplemented with 10% fetal bovine serum (Gibco). For co-
transfection experiments, HeLa cells were transfected with 2 Wg of
each plasmid (total 4 Wg) using 10 Wl of LipofectAMINE 2000 reagent
(Life Technologies) in 35 mm dishes according to the manufacturer’s
protocol. Transfected cells were processed 18 h after transfection for
immunoblot analysis.
2.3. Yeast two-hybrid analysis
The yeast two-hybrid screen was performed as previously described
[30]. Brie£y, L40 cells were transformed sequentially with the pLex-
mApg5 bait plasmid and pGAD10, encoding a mouse cDNA library,
derived from 17-day-post-coitum embryos, fused to the GAL4 activa-
tion domain (Clontech). Transformants were then selected for growth
on Sc-Trp-Leu-His plates containing 1^2 mM 3-aminotriazole for 4^8
days. Prey plasmids containing library cDNA inserts were isolated
from potential positive clones. Positives were con¢rmed by testing
pGAD10-cDNA against the empty pBTM116 plasmid. The cDNA
inserts were sequenced using the primer 5P-TTCGATGATGAAGA-
TACC-3P.
Subsequent two-hybrid interaction analyses co-transformed each
pGBD and pGAD plasmid into PJ69-4A cells. Transformants were
selected on Sc-Lrp-Leu plates and tested for growth on Sc-Trp-Leu-
His plates containing 3 mM 3-aminotriazole.
2.4. Immunoblot analysis
Yeast cell lysates were prepared by NaOH/2-mercaptoethanol ex-
traction as described in [31]. Lysates were subjected to SDS^PAGE
(sodium dodecyl sulfate^polyacrylamide gel electrophoresis) and im-
munoblotting using a⁄nity-puri¢ed anti-human Apg5 (SO4, 1:2000)
and anti-mouse Apg12 (NM2, 1:2000) [17], followed by development
with peroxidase-conjugated goat anti-rabbit IgG secondary antibody
(Jackson Immuno Research Laboratories).
Total cell lysates from HeLa cells were prepared by direct lysis in
150 Wl of 2U SDS sample bu¡er. Following boiling, lysate aliquots
(10 Wl) were separated by SDS^PAGE, then subjected to immunoblot
analysis using a mouse monoclonal anti-HA antibody (16B12, BAb-
CO) and peroxidase-conjugated rabbit anti-mouse IgG secondary
antibody (Jackson Immuno Research Laboratories).
3. Results
3.1. Identi¢cation of mouse Apg10
To identify proteins that recognize Apg5, we performed a
yeast two-hybrid screen using the yeast and mammalian Apg5
proteins as baits. When yeast Apg5 was tested against a yeast
genomic library, all positive clones contained the sequence
encoding Apg16 (T. Shintani, N. Mizushima and Y. Ohsumi,
unpublished observation), which functions to cross-link the
Apg12^Apg5 conjugate; cross-linking generates a 350-kDa
protein complex [31,32]. To perform a two-hybrid screen us-
ing mApg5 as bait, we sequentially transformed the yeast
strain with the bait plasmid (pLex-mApg5) and the prey plas-
mids containing the 17-day p.c. mouse embryonic cDNA li-
brary fused to the GAL4 activation domain. Five of the
3U107 transformants screened were positive. DNA sequenc-
ing and restriction enzyme analysis revealed that the ¢ve
clones possessed identical plasmids, containing a full-length
cDNA encoding a novel protein of 211 amino acids. This
protein has 19% identity with yeast Apg10 (Fig. 1). The amino
acid sequence surrounding the active site cysteine (HPCxT)
is conserved between yeast and mouse (Fig. 1). It is also
conserved in the potential Apg10 homologs in humans
(NP_113670.1) and nematodes (NP_495839.1) (data not
shown). We designated this protein mouse Apg10 (mApg10).
3.2. Interaction of mApg10 with other mammalian Apg proteins
We next examined the interactions of mApg12, mApg7,
mApg10 and mApg5 using the GAL4 two-hybrid system
[28]. We con¢rmed that mApg10 interacts with mApg5 (Fig.
2A). Speci¢c interactions between mApg12 and mApg7 were
also observed in this system [25]. In addition, we determined
that mApg10 binds mApg7, suggesting that mApg10 func-
tions to conjugate mApg12 with mApg5 following activation
by mApg7.
In yeast, mApg12 does not bind mApg10 (Fig. 2A). In a
yeast strain transformed with mApg7, however, mApg12 and
mApg10 interacted productively (Fig. 2B). This interaction
was not observed in host cells expressing the mApg7C567S mu-
tant, in which the active site cysteine has been replaced with
serine. This suggests that the interaction between mApg12 and
mApg10 requires activation of mApg12 by mApg7.
Fig. 1. Comparison of the deduced amino acid sequence of mApg10
(Mm) with S. cerevisiae Apg10 (Sc). The nucleotide sequence of
mApg10 has been deposited in the DDBJ/EMBL/GenBank data-
bases under accession number AB091691. Closed boxes represent
identical amino acids. The asterisk indicates the putative active site
cysteine residue conserved in mouse and yeast Apg10.
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3.3. mApg7 and mApg10-dependent two-hybrid interaction of
mApg12 and mApg5
The two-hybrid interaction between mApg12 and mApg5
was not observed in a conventional host strain, suggesting
that these proteins have no a⁄nity for each other (Fig. 2A).
Upon co-expression of mApg7 and mApg10, however, we
detected strong two-hybrid interaction between mApg12 and
mApg5 (Fig. 3C). Expression of either mApg7 or mApg10
alone did not result in positive mApg12^mApg5 interaction,
indicating that both mApg7 and mApg10 are required for
interaction. This result also suggests that the endogenous
yeast Apg7 and Apg10 could not compensate for the lack of
the mouse counterparts. Replacement of mApg10 Cys165
with Ser resulted in a complete loss of mApg10 function,
suggesting that Cys165 is indeed an active site cysteine (Fig.
3C). In yeast cells expressing mApg7C567S, only weak interac-
tions between mApg12 and mApg5 could be observed. As a
stable ester instead of a transient thioester bond would be
formed between mApg12 and mApg7 [19,21], it is unlikely
that the mApg7C567S mutant has partial activity. The incom-
plete penetrance of the mutant phenotype may result from
intermolecular complementation between yeast Apg7 and
mApg7C567S ; mApg12 may be activated by mApg7 to form
a thioester with yeast Apg7, prior to transfer to mApg10.
3.4. mApg10 is required for mApg12^mApg5 conjugation
To con¢rm that the two-hybrid interaction between
mApg12 and mApg5 (Fig. 3C) represents the formation of
Fig. 2. Interactions between mouse Apg proteins involved in the
Apg12 system determined by yeast two-hybrid analysis. PJ69-4A
cells (A) or PJ69-4A cells expressing either mApg7 or the
mApg7C567S mutant (B) were co-transformed with each of the indi-
cated GBD- and GAD-fused plasmids. We then determined growth
on Sc-Trp-Leu-His (A) or Sc-Trp-Leu-His-Ura (B) plates containing
3 mM 3-aminotriazole.
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Fig. 3. mApg7 and mApg10-dependent two-hybrid interactions be-
tween mApg12 and mApg5. PJ69-4A cells were transformed with
combinations of the indicated plasmids (A). Selected colonies are
streaked onto Sc-Trp-Leu-Ura-Ade plates (B) and Trp-Leu-Ura-
Ade-His-plates containing 3 mM 3-aminotriazole.
Fig. 4. Reconstitution of mApg12^mApg5 conjugation in yeast cells. PJ69-4A cells were transformed with combinations of the indicated plas-
mids. Total cell lysates were subjected to immunoblot analysis using anti-hApg5 and anti-mApg12 antibodies. The mobilities of the mApg12^
mApg5 conjugate, unconjugated mApg5 and unconjugated mApg12 are indicated.
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the mApg12^mApg5 conjugate, we introduced into a single
yeast strain untagged mApg12 and mApg5 with mApg7 and/
or mApg10. The mApg12^mApg5 conjugate was only gener-
ated in yeast cells expressing the wild-type forms of both
mApg7 and mApg10 (Fig. 4, lanes 4 and 10). Replacement
of the wild-type mApg7 with the mApg7C567S mutant abro-
gated conjugate formation as measured by immunoblotting
(Fig. 4, lanes 5 and 11). mApg10C165S has no activity as ob-
served by the two-hybrid analyses (Fig. 4, lanes 6 and 12).
These results suggest that functional mApg7 and mApg10
molecules are required to catalyze mApg12^mApg5 conjuga-
tion.
3.5. mApg10 forms a conjugate with mApg12 in mammalian
cells
We demonstrated that mApg10 forms a conjugate with
mApg12 in mammalian cells. Transfection of HeLa cells
with HA-tagged mApg12 cDNA resulted in generation
of two speci¢c bands on immunoblotting, identi¢ed as
HAmApg12 and the HAmApg12^mApg5 conjugate (Fig. 5,
lane 2). Co-transfection of the mApg10C165S mutant with
Apg5 and Apg12 led to the appearance of an additional
band, which was resistant to reducing agents such as 2-mer-
captoethanol (Fig. 5, lane 4). As co-transfection of the wild-
type mApg10 did not generate this band (data not shown), it
likely represents a HAmApg12^mApg10 ester. This result sug-
gests that mApg12 and wild-type mApg10 can interact with
each other in mammalian cells, likely through a transient
thioester bond formed between the C-terminal glycine of
mApg12 and Cys165 of mApg10.
4. Discussion
We have described the cloning and characterization of
mApg10. Identi¢cation of mApg10 by two-hybrid screen us-
ing mApg5 as bait suggests that mApg10 interacts directly
with mApg5. This result was unexpected, because an interac-
tion between yeast Apg10 and yeast Apg5 was not detectable
even when using the LexA system (N. Mizushima, T. Shintani
and Y. Ohsumi, unpublished observation). The interaction
was also not evidenced in the recent comprehensive two-hy-
brid analyses in yeast [33,34]. Minimal di¡erences in the ter-
tiary structure of these complexes may explain the positive
two-hybrid interaction observed for the mammalian mole-
cules. Attempts to demonstrate the interaction between
mApg10 and mApg5 by in vitro pull-down assay, however,
did not succeed, suggesting the interaction may be very weak
or transient. Alternatively, an unknown endogenous yeast
protein(s), which functions as E3s in yeast Apg12^Apg5 con-
jugation, may mediate mApg10^mApg5 interaction and
mApg12^mApg5 conjugation in the arti¢cial system described
above. We assume that the probability of this situation occur-
ring is quite low as the mouse homologs involved in the
Apg12 system exhibit little homology to the yeast counter-
parts. Mammalian Apg12 and Apg5 could not complement
the corresponding yeast apg mutants (unpublished observa-
tion), and yeast Apg7 and Apg10 cannot catalyze mApg12^
mApg5 conjugation (Figs. 2 and 3). Therefore, it is unlikely
that an unknown E3-equivalent would be functional in both
the yeast and mammalian systems. Reconstitution of the
mouse Apg12 conjugation system in yeast suggests that these
components are su⁄cient for formation of the Apg12^Apg5
conjugate and that no additional E3-like proteins are re-
quired.
In this study, we utilized a modi¢ed type of yeast two-hy-
brid assay. When conventional host yeast cells were used,
interactions between mApg12 and mApg10 and between
mApg12 and mApg5 were not detected. If the host cells ex-
pressed mApg7 or both mApg7 and mApg10, positive inter-
actions between mApg12 and mApg10 and between mApg12
and mApg5 could be identi¢ed, respectively. Non-functional
mutants of mApg7 and mApg10 could not promote the pos-
itive two-hybrid interactions, suggesting these components do
not function as simple sca¡olds in a ‘three-hybrid’ or ‘four-
hybrid’ interaction. As mApg7 and mApg10 catalyzed the
mApg12^mApg5 conjugation reaction in yeast cells (Fig. 4),
we believe that the positive two-hybrid interactions between
mApg12 and mApg10 and between mApg12 and mApg5 re-
sult from covalent linkages. Thus, we propose the use of a
modi¢ed two-hybrid system, ‘conjugation-mediated yeast two-
hybrid analysis’, as a method to identify additional molecules
necessary for conjugate formation. To date, four protein^pro-
tein conjugation systems have been explored in detail (ubiq-
uitin, SUMO, Nedd8 and Apg12). There are also additional
putative conjugation systems, such as the Urm1 [35], Hub1
[36], and UCRP systems [37], which are less well-character-
ized. In these systems, the target substrates and conjugating
enzymes involved are not fully understood. Thus, such a ‘con-
jugation-mediated two-hybrid system’ could be utilized to
identify the conjugating enzymes and substrates functioning
in these conjugation systems. Indeed, we screened mutants
destroying the two-hybrid interaction between yeast Apg12
and yeast Apg5 and obtained several apg7 mutants (T. Shin-
tani, N. Mizushima and Y. Ohsumi, unpublished observa-
tion). We propose this novel two-hybrid technique as a useful
tool for the exploration of other protein^protein conjugation
systems.
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